Cargando…
LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway
BACKGROUND: Adriamycin (ADR) resistance is one of the main obstacles to improving the clinical prognosis of breast cancer patients. Long noncoding RNAs (lncRNAs) can regulate cell behavior, but the role of these RNAs in the anti-ADR activity of breast cancer remains unclear. Here, we aim to investig...
Autores principales: | Zhang, Ming, Wang, Yan, Jiang, Longyang, Song, Xinyue, Zheng, Ang, Gao, Hua, Wei, Minjie, Zhao, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7830819/ https://www.ncbi.nlm.nih.gov/pubmed/33494806 http://dx.doi.org/10.1186/s13046-021-01844-7 |
Ejemplares similares
-
Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker
por: Torkashvand, Safoora, et al.
Publicado: (2021) -
Investigation of miRNA- and lncRNA-mediated competing endogenous RNA network in cholangiocarcinoma
por: He, Yanxin, et al.
Publicado: (2019) -
Analysis of the lncRNA-Associated Competing Endogenous RNA (ceRNA) Network for Tendinopathy
por: Huang, Bing-Zhe, et al.
Publicado: (2022) -
Comprehensive Analysis of RNA-Seq in Endometriosis Reveals Competing Endogenous RNA Network Composed of circRNA, lncRNA and mRNA
por: Yin, Meichen, et al.
Publicado: (2022) -
Comprehensive analysis of the lncRNA-associated competing endogenous RNA network in breast cancer
por: Wang, Jing-Jing, et al.
Publicado: (2019)